Regulatory Comment Letter
Comments on Sec. 301 Product Exclusions Related to COVID-19
Regulatory Comment Letter
Comments on Sec. 301 Product Exclusions Related to COVID-19
RILA urges the Administration to extend the Section 301 tariff exclusions on essential medical items as tariffs on COVID-related products will harm American businesses, workers, and consumers during an unparalleled crisis.